Evidence map›Paper›PMID 30874590›Full record

ArticleScientific reports2019

Applications and limitations of fitting of the operational model to determine relative efficacies of agonists.

Jan Jakubík, Alena Randáková, Vladimír Rudajev, Pavel Zimčík, Esam E El-Fakahany, Vladimír Doležal

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.5field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 26 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Cancer-Associated Mutations of the Adenosine AMolecules (Basel, Switzerland) · 2022
    Article
  8. Employing the Operational Model to Measure System-Independent OTR Efficacy.Methods in molecular biology (Clifton, N.J.) · 2022
    Article
  9. Fusion with Promiscuous GαInternational journal of molecular sciences · 2021
    Article
  10. Novel MBritish journal of pharmacology · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 2 countries.

Jan JakubíkInstitute of Physiology CAS, 142 20, Prague, Czech Republic. jan.jakubik@fgu.cas.cz.ORCID 0000-0002-1737-1487
Alena RandákováInstitute of Physiology CAS, 142 20, Prague, Czech Republic.
Vladimír RudajevInstitute of Physiology CAS, 142 20, Prague, Czech Republic.
Pavel ZimčíkInstitute of Physiology CAS, 142 20, Prague, Czech Republic.
Esam E El-FakahanyDepartment of Experimental and Clinical Pharmacology, University of Minnesota College of Pharmacy, Minneapolis, MN, 55455, USA.
Vladimír DoležalInstitute of Physiology CAS, 142 20, Prague, Czech Republic.
Czech Academy of Sciences, Institute of Physiology · CZUniversity of Minnesota · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Proper determination of agonist efficacy is essential in the assessment of agonist selectivity and signalling bias. Agonist efficacy is a relative term that is dependent on the system in which it is measured, especially being dependent on receptor expression level. The operational model (OM) of functional receptor agonism is a useful means for the determination of agonist functional efficacy using the maximal response to agonist and ratio of agonist functional potency to its equilibrium dissociation constant (K

Identifiers

PMID30874590
PMCPMC6420642
OpenAlexW2921670360

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.